SCHEMBL24695709

SCHEMBL24695709

Cc1cc(C(F)(F)F)cc(O)c1-c1cnc(N)nn1

nearest known ligand 0.51

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ IL1B P01584 20/20 0.51
▸ TNF P01375 3/20 0.50
▸ NLRP3 Q96P20 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25864733 0.82 KDM4E (0.39) IL1BTNFNLRP3
SCHEMBL24695405 0.81 ALOX5AP (0.40) IL1BTNFNLRP3
SCHEMBL22695042 0.79 IL1B (0.57) IL1BTNFNLRP3
SCHEMBL22670556 0.78 IL1B (0.60) IL1BTNFNLRP3
SCHEMBL22695045 0.77 IL1B (0.61) IL1BTNFNLRP3
SCHEMBL26093443 0.75 ALOX5AP (0.36) IL1BTNFNLRP3
SCHEMBL24695419 0.74 IL1B (0.49) IL1BTNFNLRP3
SCHEMBL22655138 0.74 IL1B (0.57) IL1BTNFNLRP3
SCHEMBL26434234 0.73 IL1B (0.57) IL1BTNF
SCHEMBL31233716 0.72 IL1B (0.51) IL1BTNFNLRP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022253936-A1 TRIAZINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER. F. HOFFMANN-LA ROCHE AG (CH) 2022-12-08 — — WO disclosed
Send feedback